The dry powder inhaler market is projected to grow from USD 21.6 billion in 2025 to USD 30.5 billion by 2035, at a CAGR of 3.5%. Multi Dose Dry Powder Inhalers will dominate with a 59.4% market share, while asthma will lead the indication segment with a 42.7% share.